Preprint Communication Version 1 Preserved in Portico This version is not peer-reviewed

Omicron Sublineages Current Status in Ecuador

Version 1 : Received: 19 April 2022 / Approved: 21 April 2022 / Online: 21 April 2022 (08:24:19 CEST)

A peer-reviewed article of this Preprint also exists.

Carrazco-Montalvo, A.; Herrera-Yela, A.; Alarcón-Vallejo, D.; Gutiérrez-Pallo, D.; Armendáriz-Castillo, I.; Andrade-Molina, D.; Muñoz-Mawyin, K.; Fernández-Cadena, J.C.; Morey-León, G.; USFQ-COVID-19 Consortium; CRN Influenza y OVR—INSPI; Patiño, L. Omicron Sub-Lineages (BA.1.1.529 + BA.*) Current Status in Ecuador. Viruses 2022, 14, 1177. Carrazco-Montalvo, A.; Herrera-Yela, A.; Alarcón-Vallejo, D.; Gutiérrez-Pallo, D.; Armendáriz-Castillo, I.; Andrade-Molina, D.; Muñoz-Mawyin, K.; Fernández-Cadena, J.C.; Morey-León, G.; USFQ-COVID-19 Consortium; CRN Influenza y OVR—INSPI; Patiño, L. Omicron Sub-Lineages (BA.1.1.529 + BA.*) Current Status in Ecuador. Viruses 2022, 14, 1177.

Abstract

The Omicron variant of SARS-CoV-2 is the latest pandemic lineage causing COVID-19. Despite having a vaccination rate ≥ 85% Ecuador recorded a high incidence of Omicron from December 2021 to March 2022. Since Omicron emerged it is evolving into multiple sublineages with distinct prevalence in different regions. In this work, we use all Omicron sequences from Ecuador available at GISAID until March 2022 and the software Nextclade and Pangolin to identify which lineages circulate in this country. We detected 12 different sublineages (BA.1, BA.1.1, BA.1.1.1, BA.1.1.14, BA.1.1.2, BA.1.14, BA.1.15, BA.1.16, BA.1.17, BA.1.6, BA.2, BA.2.3), which has been reported in Africa, America, Europe, and Asia suggesting multiple introduction events. Sublineages BA.1.1 and BA.1 were the most prevalent. Genomic surveillance must continue to evaluate the dynamic of current sublineages, early introduction of new ones and vaccine efficacy against evolving SARS-CoV-2.

Keywords

COVID-19; Omicron; Sublineages; Ecuador

Subject

Biology and Life Sciences, Biochemistry and Molecular Biology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.